Association between CARD8 rs2043211 polymorphism and inflammatory bowel disease: A meta-analysis

Immunological Investigations

Volumn 44, Issue 3, 2015, Pages 253-264

  Liu, Juan ^a   Liu, Yan Yan ^a   Liu, Jie ^a   Li, Bao Zhu ^a   Cen, Han ^a   Xu, Wang Dong ^a   Leng, Rui Xue ^a   Pan, Hai Feng ^a   Ye, Dong Qing ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

CARD8; Inflammatory bowel disease; Meta analysis; Polymorphism

Indexed keywords

CARRIER PROTEINS AND BINDING PROTEINS; CASPASE RECRUITMENT DOMAIN PROTEIN 8; UNCLASSIFIED DRUG; CARD8 PROTEIN, HUMAN; CASPASE RECRUITMENT DOMAIN SIGNALING PROTEIN; TUMOR PROTEIN;

ALLELE; ARTICLE; CROHN DISEASE; ETHNICITY; EUROPEAN; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; HOMOZYGOTE; HUMAN; INFLAMMATORY BOWEL DISEASE; META ANALYSIS; PRIORITY JOURNAL; PUBLISHING; RECESSIVE INHERITANCE; ULCERATIVE COLITIS; CAUCASIAN; DOMINANT GENE; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; CARD SIGNALING ADAPTOR PROTEINS; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENES, DOMINANT; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HOMOZYGOTE; HUMANS; INFLAMMATORY BOWEL DISEASES; NEOPLASM PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84928012424     PISSN: 08820139     EISSN: 15324311     Source Type: Journal    
DOI: 10.3109/08820139.2014.988721     Document Type: Article

References (39)

1. Abraham BP, Mehta S, El-Serag HB. (2012). Natural history of pediatric-onset inflammatory bowel disease. J Clin Gastroenterol, 46, 581-9.
2. Abraham C, Cho JH. (2009). Inflammatory bowel disease. N Engl J Med, 361, 2066-78.
3. Adams SM, Bornemann PH. (2013). Ulcerative colitis. Am Fam Physician, 87, 699-705.
4. Agostini L, Martinon F, Burns K, et al. (2004). NALP3 forms an IL-1beta processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity, 20, 319-25.
5. Anderson CA, Boucher G, Lees CW, et al. (2011). Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat Genet, 43, 246-52.
6. Bagnall RD, Roberts RG, Mirza MM, et al. (2008). Novel isoforms of the CARD8 (TUCAN) gene evade a nonsense mutation. Eur J Hum Genet, 16, 619-25.
7. Bouchier-Hayes L, Conroy H, Egan H, et al. (2001). CARDINAL, a novel caspase recruitment domain protein, is an inhibitor of multiple NF-kappa B activation pathways. J Biol Chem, 276, 44069-77.
8. Bouma G, Strober W. (2003). The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol, 3, 521-33.
9. Bu ning C, Schmidt HH, Molnar T, et al. (2008). No association of the CARD8 (TUCAN) c.30T4A (p.C10X) variant with Crohn's disease: a study in 3 independent European cohorts. Inflamm Bowel Dis, 14, 332-7.
10. Egger M, Davey Smith G, Schneider M, et al. (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-34.
11. Fisher SA, Mirza MM, Onnie CM, et al. (2007). Combined evidence from three large British Association studies rejects TUCAN/CARD8 as an IBD susceptibility gene. Gastroenterology, 132, 2078-80.
12. Fontalba A, Gutierrez O, Llorca J, Mateo I, et al. (2008). Deficiency of CARD8 is associated with increased Alzheimer's disease risk in women. Dement Geriatr Cogn Disord, 26, 247-50.
13. Fontalba A, Martinez-Taboada V, Gutierrez O, et al. (2007). Deficiency of the NFkappaB inhibitor caspase activating and recruitment domain 8 in patients with rheumatoid arthritis is associated with disease severity. J Immunol, 179, 4867-73.
14. Franchimont D, Vermeire S, El Housni H, et al. (2004). Deficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitis. Gut, 53, 987-92.
15. Franke A, McGovern DP, Barrett JC, et al. (2010). Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat Genet, 42, 1118-25.
16. Franke A, Rosenstiel P, Balschun T, et al. (2007). No association between the TUCAN (CARD8) Cys10Stop mutation and inflammatory bowel disease in a large retrospective German and a clinically well-characterized Norwegian sample. Gastroenterology, 132, 2080-1.
17. Geboes K, Van Eyken P. (2009). Inflammatory bowel disease unclassified and indeterminate colitis: the role of the pathologist. J Clin Pathol, 62, 201-5.
18. Glas J, Endres I, Tonenchi L, et al. (2009). Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease. Am J Gastroenterol, 104, 1723-33.
19. Halfvarson J. (2011). Genetics in twins with Crohn's disease: less pronounced than previously believed? Inflamm Bowel Dis, 17, 6-12.
20. Hedrick TL, Friel CM. (2013). Colonic Crohn disease. Clin Colon Rectal Surg, 26(2), 84-9.
21. Henckaerts L, Pierik M, Joossens M, et al. (2007). Mutations in pattern recognition receptor genes modulate seroreactivity to microbial antigens in patients with inflammatory bowel disease. Gut, 56, 1536-42.
22. Higgins JP, Thompson SG. (2002). Quantifying heterogeneity in a meta-analysis. Stat Med, 21, 1539-58.
23. Hugot JP, Chamaillard M, Zouali H, et al. (2001). Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature, 411, 599-603.
24. Kastbom A, Klingberg E, Verma D, et al. (2013). Genetic variants in CARD8 but not in NLRP3 are associated with ankylosing spondylitis. Scand J Rheumatol, 42, 465-8.
25. Khor B, Gardet A, Xavier RJ. (2011). Genetics and pathogenesis of inflammatory bowel disease. Nature, 474, 307-17.
26. Ko DC, Shukla KP, Fong C, et al. (2009). A genome-wide in vitro bacterial-infection screen reveals human variation in the host response associated with inflammatory disease. Am J Hum Genet, 85, 214-27.
27. McGovern DP, Butler H, Ahmad T, et al. (2006). TUCAN (CARD8) genetic variants and inflammatory bowel disease. Gastroenterology, 131, 1190-6.
28. McGovern DP, Hysi P, Ahmad T, et al. (2005). Association between a complex insertion/deletion polymorphism in NOD1 (CARD4) and susceptibility to inflammatory bowel disease. Hum Mol Genet, 14, 1245-50.
29. Ogura Y, Bonen DK, Inohara N, et al. (2001). A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature, 411, 603-6.
30. Pathan N, Marusawa H, Krajewska M, et al. (2001). TUCAN, an antiapoptotic caspaseassociated recruitment domain family protein overexpressed in cancer. J Biol Chem, 276, 32220-9.
31. Razmara M, Srinivasula SM, Wang L, et al. (2002). CARD-8 protein, a new CARD family member that regulates caspase-1 activation and apoptosis. J Biol Chem, 277, 13952-8.
32. Roberts RL, Topless RK, Phipps-Green AJ, et al. (2010). Evidence of interaction of CARD8 rs2043211 with NALP3 rs35829419 in Crohn's disease. Genes Immun, 11, 351-6.
33. Schoultz I, Verma D, Halfvarsson J, et al. (2009). Combined polymorphisms in genes encoding the inflammasome components NALP3 and CARD8 confer susceptibility to Crohn's disease in Swedish men. Am J Gastroenterol, 104, 1180-8.
34. Stilo R, Leonardi A, Formisano L, et al. (2002). TUCAN/CARDINAL and DRAL participate in a common pathway for modulation of NF-kappaB activation. FEBS Lett, 521, 165-9.
35. Thompson NP, Driscoll R, Pounder RE, et al. (1996). Genetics versus environment in inflammatory bowel disease: results of a British twin study. Br Med J, 312, 95-6.
36. Von Kampen O, Lipinski S, Till A, et al. (2010). Caspase recruitment domain-containing protein 8 (CARD8) negatively regulates NOD2-mediated signaling. J Biol Chem, 285, 19921-6.
37. Xavier RJ, Podolsky DK. (2007). Unravelling the pathogenesis of inflammatory bowel disease. Nature, 448, 427-34.
38. Yamamoto M, Torigoe T, Kamiguchi K, et al. (2005). A novel isoform of TUCAN is overexpressed in human cancer tissues and suppresses both caspase-8-and caspase-9-mediated apoptosis. Cancer Res, 65, 8706-14.
39. Yang SK, Kim H, Hong M, et al. (2011). Association of CARD8 with inflammatory bowel disease in Koreans. J Hum Genet, 56, 217-23.